Francini, E., Gray, K. P., Xie, W., Shaw, G. K., Valença, L., Bernard, B., . . . Sweeney, C. J. (2018). Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC). The Prostate, 78(12), 889-895. https://doi.org/10.1002/pros.23645
Chicago-Zitierstil (17. Ausg.)Francini, Edoardo, et al. "Time of Metastatic Disease Presentation and Volume of Disease Are Prognostic for Metastatic Hormone Sensitive Prostate Cancer (mHSPC)." The Prostate 78, no. 12 (2018): 889-895. https://doi.org/10.1002/pros.23645.
MLA-Zitierstil (9. Ausg.)Francini, Edoardo, et al. "Time of Metastatic Disease Presentation and Volume of Disease Are Prognostic for Metastatic Hormone Sensitive Prostate Cancer (mHSPC)." The Prostate, vol. 78, no. 12, 2018, pp. 889-895, https://doi.org/10.1002/pros.23645.